5H-茚并[1,2-c]异喹啉-5-酮,6,11-二氢- | 109722-74-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异喹啉及其衍生物
• 中文名称: 5H-茚并[1,2-c]异喹啉-5-酮,6,11-二氢-
• 英文名称: 5,6-dihydro-5-oxo-indeno[1,2-c]isoquinoline
• 英文别名: 6H-indeno[1,2-c]isoquinolin-5-(11H)-one；5,6-dihydro-5-oxo-11H-indeno-[1,2-c]isoquinoline；5,6-dihydro-5-oxo-11H-indeno[1,2-c]isoquinoline；5,6-dihydro-5-oxo-11H-indeno [1,2-c]isoquinoline；6,11-dihydroindeno[1,2-c]isoquinolin-5-one
• CAS: 109722-74-9
• 化学式: C₁₆H₁₁NO
• 分子量: 233.269
• InChiKey: MOPKKHSEOPGEBJ-UHFFFAOYSA-N

物化性质

• 熔点：
  >300 °C(Solv: acetic acid (64-19-7))
• 沸点：
  491.8±45.0 °C(Predicted)
• 密度：
  1.33±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  18
• 可旋转键数：
  0
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.06
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  5H-茚并[1,2-c]异喹啉-5-酮,6,11-二氢- 在 磺酰氯 、 三乙胺 作用下， 以 二氯甲烷 为溶剂， 反应 2.0h， 生成 8-oxo-N-(3-phenylpropyl)-9-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaene-14-sulfonamide
  参考文献：
  名称：

  Discovery of Potent Poly(ADP-ribose) Polymerase-1 Inhibitors from the Modification of Indeno[1,2-c]isoquinolinone

  摘要：

  Novel indeno[1,2-c]isoquinolinone derivatives were synthesized and evaluated as inhibitors of the nuclear enzyme poly(ADP-ribose) polymerase-1 (PARP-1). These potent nonmutagenic PARP-1 inhibitors possess an additional five-membered ring between the B and C rings of 6(5H)-phenanthridinone. The most potent PARP-1 inhibitors were obtained from the substitution of the D ring at the C-9 position, in particular sulfonamide and N-acyl analogues (6 and 11). The 9-sulfonamide analogues 11a and 12a exhibited IC50 values of 1 and 10 nM, respectively.

  DOI：

  10.1021/jm0502891
• 作为产物：
  描述：

  苯并[d]茚并[1,2-b]吡喃-5,11-二酮 在 三乙基硅烷 、 氨 、 三氟乙酸 作用下， 以 甲醇 为溶剂， 反应 120.0h， 生成 5H-茚并[1,2-c]异喹啉-5-酮,6,11-二氢-
  参考文献：
  名称：

  Discovery of Potent Poly(ADP-ribose) Polymerase-1 Inhibitors from the Modification of Indeno[1,2-c]isoquinolinone

  摘要：

  Novel indeno[1,2-c]isoquinolinone derivatives were synthesized and evaluated as inhibitors of the nuclear enzyme poly(ADP-ribose) polymerase-1 (PARP-1). These potent nonmutagenic PARP-1 inhibitors possess an additional five-membered ring between the B and C rings of 6(5H)-phenanthridinone. The most potent PARP-1 inhibitors were obtained from the substitution of the D ring at the C-9 position, in particular sulfonamide and N-acyl analogues (6 and 11). The 9-sulfonamide analogues 11a and 12a exhibited IC50 values of 1 and 10 nM, respectively.

  DOI：

  10.1021/jm0502891

文献信息

• Isoquinoline derivatives and methods of use thereof
  申请人：——

  公开号：US20040039009A1

  公开（公告）日：2004-02-26

  The invention provides novel classes of Isoquinoline Derivatives. Pharmaceutical compositions and methods of making and using the compounds, are also described.

  这项发明提供了新型的异喹啉衍生物。还描述了制备和使用这些化合物的药物组合物和方法。
• [EN] ISOQUINOLINE DERIVATIVES AND METHODS OF USE THEREOF<br/>[FR] DERIVES D'ISOQUINOLINE ET METHODES D'UTILISATION
  申请人：INOTEK PHARMACEUTICALS CORP

  公开号：WO2005082368A1

  公开（公告）日：2005-09-09

  The present invention relates to Isoquinoline Derivatives, compositions comprising an effective amount of a Isoquinoline Derivative and methods for treating or preventing an inflammatory disease, a reperfusion injury, an ischemic condition, renal failure, diabetes, a diabetic complication, a vascular disease other than a cardiovascular disease, cardiovascular disease, reoxygenation injury resulting from organ transplantation, Parkinson's disease, or cancer, comprising administering to an animal in need thereof an effective amount of a Isoquinoline Derivative.

  本发明涉及异喹啉衍生物，包括含有有效量的异喹啉衍生物的组合物，以及用于治疗或预防炎症性疾病、再灌注损伤、缺血状况、肾衰竭、糖尿病、糖尿病并发症、心血管疾病以外的血管疾病、心血管疾病、器官移植导致的再氧化损伤、帕金森病或癌症的方法，包括向需要此的动物施用有效量的异喹啉衍生物。
• Methods for treating or preventing erectile dysfunction or urinary incontinence
  申请人：Szabo Csaba

  公开号：US20060019980A1

  公开（公告）日：2006-01-26

  The present invention relates to methods for treating or preventing erectile dysfunction or urinary incontinence, comprising administering to a subject in need thereof an effective amount of a compound of the invention.

  本发明涉及治疗或预防勃起功能障碍或尿失禁的方法，包括向需要的受试者施用本发明的化合物的有效量。
• One-Pot Synthesis of 3-Substituted Isoquinolin-1-(2H)-ones and Fused Isoquinolin-1-(2H)-ones by SRN1 Reactions in DMSO
  作者：Javier F. Guastavino、Silvia M. Barolo、Roberto A. Rossi

  DOI：10.1002/ejoc.200600244

  日期：2006.9

  3-Substituted isoquinolin-1-(2H)-ones and fused isoquinolin-1-(2H)-ones have been obtained by the photostimulated SRN1 reactions of 2-iodobenzamide with the enolates of aromatic (acetophenone, 1-(benzo[d][1,3]dioxol-5-yl)ethanone, 1- and 2-naphthyl methyl ketones, and 2-, 3-, and 4-acetylpyridine), aliphatic (1-adamantyl methyl ketone), and cyclic ketones (1- and 2-indanone, α- and β-tetralone, and

  3-取代的异喹啉-1-(2H)-酮和稠合的异喹啉-1-(2H)-酮是通过 2-碘苯甲酰胺与芳香族（苯乙酮，1-（苯并[d]）的烯醇化物的光刺激 SRN1 反应获得的[1,3]dioxol-5-yl)ethanone, 1- and 2-naphthylmethyl ketones, and 2-, 3-, and 4-acetylpyridine), 脂肪族（1-adamantylmethyl ketone）和环酮（1-和 2-茚满酮、α-和β-四氢萘酮以及 1-苯并芴酮）在 DMSO 中。(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2006)
• Indenoisoquinolinone analogs and methods of use thereof
  申请人：Jagtap Prakash

  公开号：US20070049555A1

  公开（公告）日：2007-03-01

  The present invention relates to Indenoisoquinolinone Analogs, compositions comprising an effective amount of an Indenoisoquinolinone Analog and methods for treating or preventing an inflammatory disease, a reperfusion injury, diabetes mellitus, a diabetic complication, reoxygenation injury resulting from organ transplantation, an ischemic condition, a neurodegenerative disease, renal failure, a vascular disease, a cardiovascular disease, cancer, a complication of prematurity, cardiomyopathy, retinopathy, nephropathy, neuropathy, erectile dysfunction or urinary incontinence, comprising administering to a subject in need thereof an effective amount of an Indenoisoquinolinone Analog.

  本发明涉及Indenoisoquinolinone类似物，包括有效量的Indenoisoquinolinone类似物的组合物，以及用于治疗或预防炎症性疾病、再灌注损伤、糖尿病、糖尿病并发症、器官移植引起的再氧化损伤、缺血状况、神经退行性疾病、肾功能衰竭、血管疾病、心血管疾病、癌症、早产并发症、心肌病、视网膜病、肾病、神经病、勃起功能障碍或尿失禁的方法，包括向需要治疗的受体内给予有效量的Indenoisoquinolinone类似物。